411 related articles for article (PubMed ID: 204188)
1. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
Patsch JR; Yeshurun D; Jackson RL; Gotto AM
Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
[No Abstract] [Full Text] [Related]
2. [Familial hyperlipoproteinemia type III].
Patsch JR; Patsch W; Sailer S; Braunsteiner H
Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039
[No Abstract] [Full Text] [Related]
3. Xanthomatosis and hyperlipoproteinemia; a review.
Polano MK
Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
[No Abstract] [Full Text] [Related]
4. Dietary and drug treatment of primary hyperlipoproteinemia.
Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
[No Abstract] [Full Text] [Related]
5. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
[No Abstract] [Full Text] [Related]
6. A physician's guide to hyperlipidemia.
Fredrickson DS
Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098
[No Abstract] [Full Text] [Related]
7. Treatment of hyperlipidemia.
Levy RI; Morganroth J; Rifkind BM
N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
[No Abstract] [Full Text] [Related]
8. Altering lipid patterns in adult males.
Appelbaum JJ; Amundsen MA; Perkin DK
J Occup Med; 1974 Aug; 16(8):539-42. PubMed ID: 4367267
[No Abstract] [Full Text] [Related]
9. Hyperlipoproteinemia. Some basic concepts on diagnosis and management.
Levy RI
JAMA; 1973 Nov; 226(6):648-9. PubMed ID: 4356846
[No Abstract] [Full Text] [Related]
10. Type IV hyperlipoproteinaemia.
Kwiterovich PO; Margolis S
Clin Endocrinol Metab; 1973 Mar; 2(1):41-71. PubMed ID: 4359117
[No Abstract] [Full Text] [Related]
11. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Weisweiler P; Schwandt P
Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
[TBL] [Abstract][Full Text] [Related]
12. [The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy].
Schwartzkopff W; Zschiedrich M
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():825-9. PubMed ID: 196436
[No Abstract] [Full Text] [Related]
13. [The when and how of therapy for hyperlipoproteinemia].
Mordasini R
Schweiz Med Wochenschr; 1978 Jan; 108(4):113-9. PubMed ID: 203028
[TBL] [Abstract][Full Text] [Related]
14. [Hyperlipoproteinemia].
Meinders AE
Ned Tijdschr Geneeskd; 1979 Mar; 123(15):617-28. PubMed ID: 219378
[No Abstract] [Full Text] [Related]
15. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
Carlson LA; Olsson G; Ballantyne D
Atherosclerosis; 1977 Apr; 26(4):603-9. PubMed ID: 193526
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypolipidemic drugs on serum lipoproteins.
Carlson LA; Olsson AG
Prog Biochem Pharmacol; 1979; 15():238-57. PubMed ID: 224397
[No Abstract] [Full Text] [Related]
17. Bile acid metabolism in hyperlipoproteinaemia.
Hellström K; Einarsson K
Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
[No Abstract] [Full Text] [Related]
18. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
Weisweiler P; Schwandt P
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
[No Abstract] [Full Text] [Related]
19. Antihyperlipidaemic agents.
Witte EC
Prog Med Chem; 1975; 11():119-92. PubMed ID: 165566
[No Abstract] [Full Text] [Related]
20. Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
Dunnigan MG; Cochrane MA; Kelly A; Scott JW
Q J Med; 1974 Jan; 43(169):33-48. PubMed ID: 4362786
[No Abstract] [Full Text] [Related]
[Next] [New Search]